Study for the Validation of the Circuit of Examinations and Analyzes for Better Classification of Airway Diseases
NCT ID: NCT05826522
Last Updated: 2023-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2023-05-15
2023-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analyzing Lung Tissue in People With and Without Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung Transplantation
NCT00756522
Seoul National University Airway Registry
NCT02527486
Study of the Use of Non-invasive Ventilation in Bronchial Dilatation Disease
NCT06987461
Study of Microbiological Diversity in Exhaled Air in COPD and Free of COPD
NCT05437198
Controls for Respiratory Diseases
NCT03120481
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
asthmatics and asthmatics previously
observationnal
cohort of blood collection and severals exams
COPD (chronic obstructive pulmonary disease) patients
observationnal
cohort of blood collection and severals exams
cystic fibrosis patients
observationnal
cohort of blood collection and severals exams
patients with immunodeficiency with bronchial obstruction
observationnal
cohort of blood collection and severals exams
lung transplant recipients with obstructive chronic lung allograft rejection (O-CLAD)
observationnal
cohort of blood collection and severals exams
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observationnal
cohort of blood collection and severals exams
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Severe asthmatics + asthmatics previously hospitalized at least once in 2016 - 2019
* COPD patients previously hospitalized at least once in 2016 - 2019 Cystic fibrosis patients, patients with immunodeficiency, without bone marrow transplantation, and with AD determined upon bronchial obstruction (FEV1/FVC \< 70%).
* Lung transplant recipients with obstructive chronic lung allograft rejection (O-CLAD)
* Hematopoietic stem cell transplant recipients with AD determined upon bronchial obstruction.
* Patients already followed-up in pulmonology clinic at the Foch Hospital
* Patients understanding the French language
* Patients having signed an informed consent form prior to any study specific procedure
* Patients being covered by a national health insurance
Exclusion Criteria
* Immunocompromised patients, having had a bone marrow transplant and suffering from AD determined by bronchial obstruction (FEV1/FVC \> 70%).
* Patients weighing less than 50 kg
* Pregnant women
* Patients who are not followed in pulmonology consultation at Foch Hospital
* Patients don't understanding the French language
* Don't being covered by a national health insurance
* Being deprived of liberty or under guardianship
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Hopital Foch
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A01154-39
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.